AKR1B1 and neoplasm: In non-tumoral diseases, the role of AKR1B1 in EMT has been primarily investigated in the context of chronic tissue remodeling, fibrosis, and organ dysfunction—conditions frequently associated with hyperglycemia, in which the enzyme is overexpressed and hyperactivated.